NLRP12 and neoplasm: Aberrant VEGF signaling is central to the pathologic angiogenesis observed during tumor progression and in the development of retinal vascular diseases,[1] Thus, we examined the potential effects of this novel noncanonical NLRP12‐CASP8‐ASC inflammasome on VEGF signaling.